FRM
Fox Run Management’s Cogent Biosciences COGT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $189K | Sell |
26,385
-20,241
| -43% | -$145K | 0.03% | 759 |
|
|
2025
Q1 | $279K | Buy |
46,626
+36,518
| +361% | +$219K | 0.04% | 693 |
|
|
2024
Q4 | $78.8K | Sell |
10,108
-12,570
| -55% | -$98K | 0.01% | 821 |
|
|
2024
Q3 | $245K | Buy |
+22,678
| New | +$245K | 0.05% | 612 |
|
|
2023
Q4 | – | Sell |
-10,111
| Closed | -$98.6K | – | 761 |
|
|
2023
Q3 | $98.6K | Buy |
+10,111
| New | +$98.6K | 0.03% | 625 |
|
|
2022
Q4 | – | Sell |
-18,621
| Closed | -$278K | – | 662 |
|
|
2022
Q3 | $278K | Buy |
+18,621
| New | +$278K | 0.11% | 373 |
|